CHANDLER, Ariz., Aug. 14, 2017 -- Microchip Technology Inc. (NASDAQ:MCHP) today announced the MPLAB® ICD 4, an in-circuit programming and debugging development tool for Microchip’s PIC® microcontroller (MCU) and dsPIC® digital signal controller portfolios. The MPLAB ICD 4 debugger includes all the features of the popular MPLAB ICD 3 tool while adding increased speed through a faster processor and increased RAM.
The MPLAB ICD 4’s significant improvement in speed is accomplished through a 32-bit MCU running at 300 MHz. The faster processing, along with an increased buffer memory of 2 MB, results in a product that is up to twice as fast as its predecessor.
The puck-shaped MPLAB ICD 4 is housed in a durable, black case with a brushed aluminum top and is accented with an LED light strip to indicate debugging status. The tool features the following:
- A wider target voltage range, from 1.20 to 5.5 V
- An optional 1 amp of power (using an external power supply)
- Selectable pull-up/pull-down option to the target interface
- Configurable interface speed for optimized programming and debugging
- Intelligent, robust interface with fault detection and immunity
- JTAG debugging capability
Microchip’s MPLAB ICD 4 development tool is easy to use and supports all PIC microcontrollers and dsPIC digital signal controllers in Microchip’s portfolio through the MPLAB X Integrated Development Environment (IDE). This simplifies the design process for customers when they choose to migrate from one PIC MCU to another to meet the needs of their application.
“Speed and flexibility are the most important factors when selecting a debugging tool," said Rodger Richey, Microchip’s director of Development Tools. “The MPLAB ICD 4 reduces wait time—and in turn—improves debugging productivity. With speed, compatibility, durability, comprehensive device support and the award-winning MPLAB X IDE, the MPLAB ICD 4 again solidifies Microchip’s reputation as a leading provider of embedded debugging tools.”
For more information about MPLAB ICD 4, visit: www.microchip.com/ICD4
Pricing and Availability
The MPLAB ICD 4 (DV164045) is available today for $249.95. To purchase, go to Microchip’s easy-to-use online sales channel microchipDIRECT or contact one of Microchip’s authorized distribution partners. For additional information, contact any Microchip sales representative or authorized worldwide distributor, or visit Microchip’s website.
Resources
High-res image is available through Flickr or editorial contact (feel free to publish):
About Microchip Technology
Microchip Technology Inc. (NASDAQ:MCHP) is a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, providing low-risk product development, lower total system cost and faster time to market for thousands of diverse customer applications worldwide. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com.
Note: The Microchip name and logo, the Microchip logo, MPLAB, PIC and dsPIC are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.
Editorial Contact: Brian Thorsen 480-792-7182 [email protected] Reader Inquiries: 1-888-624-7435


Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Shell M&A Chief Exits After BP Takeover Proposal Rejected
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 



